Showing results (21-30 of 77) with videos related to
Sort By:
Pageof 8
European Journal of Medicinal Chemistry|September 18, 2007
Xanthine oxidase-activated prodrugs of thymidine phosphorylase inhibitorsPhilip Reigan, Abdul Gbaj, Ian J Stratford, et al.Pharmaceutical Research|November 22, 2014
Human ALDH1B1 polymorphisms may affect the metabolism of acetaldehyde and all-trans retinaldehyde--in vitro studies and computational modelingBrian C Jackson, Philip Reigan, Bettina Miller, et al.Journal of Chemical Information and Modeling|August 12, 2025
RiSKs in Computational Modeling of Isoform-Selective RSK InhibitorsVu T Nguyen, Caleb Chandler, Juliet E Strang, et al.Bioorganic & Medicinal Chemistry|April 25, 2017
Dimeric isoxazolyl-1,4-dihydropyridines have enhanced binding at the multi-drug resistance transporterScott A Steiger, Chun Li, Donald S Backos, et al.RSC Medicinal Chemistry|December 8, 2025
The structural requirements of 3,5-substituted oxindoles that determine selective AMPK or GSK3β inhibitionJuliet E Strang, Daniel D Astridge, Caleb Chandler, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|March 31, 2006
Thymidine phosphorylase from Escherichia coli: tight-binding inhibitors as enzyme active-site titrantsAbdul Gbaj, Philip N Edwards, Philip Reigan, et al.Biochemistry|April 26, 2007
Development of indolequinone mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1): NQO1 inhibition and growth inhibitory activity in human pancreatic MIA PaCa-2 cancer cellsPhilip Reigan, Marie A Colucci, David Siegel, et al.Data in Brief|October 11, 2021
Substituted pteridinones, pyrimidines, pyrrolopyrimidines, and purines as p90 ribosomal S6 protein kinase-2 (RSK2) inhibitors: Pharmacophore modeling dataBecka M Warfield, Kimberly A Casalvieri, Christopher J Matheson, et al.ACS Chemical Neuroscience|September 2, 2021
Evaluation of Thymidine Phosphorylase Inhibitors in Glioblastoma and Their Capacity for Temozolomide PotentiationBecka M Warfield, Christopher J Matheson, Debbie G McArthur, et al.Bioorganic & Medicinal Chemistry Letters|September 30, 2004
Synthesis and enzymatic evaluation of xanthine oxidase-activated prodrugs based on inhibitors of thymidine phosphorylasePhilip Reigan, Abdul Gbaj, Edwin Chinje, et al.Pageof 8